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Abstract: Interactions between blood platelets and nanoparticles have both pharmacological 
and toxicological significance and may lead to platelet activation and aggregation. Platelet 
aggregation is usually studied using light aggregometer that neither mimics the conditions found 
in human microvasculature nor detects microaggregates. A new method for the measurement of 
platelet microaggregation under flow conditions using a commercially available quartz crystal 
microbalance with dissipation (QCM-D) has recently been developed. The aim of the current 
study was to investigate if QCM-D could be used for the measurement of nanoparticle-platelet 
interactions. Silica, polystyrene, and gold nanoparticles were tested. The interactions were also 
studied using light aggregometry and flow cytometry, which measured surface abundance of 
platelet receptors. Platelet activation was imaged using phase contrast and scanning helium ion 
microscopy. QCM-D was able to measure nanoparticle-induced platelet microaggregation for 
all nanoparticles tested at concentrations that were undetectable by light aggregometry and flow 
cytometry. Microaggregates were measured by changes in frequency and dissipation, and the 
presence of platelets on the sensor surface was confirmed and imaged by phase contrast and 
scanning helium ion microscopy.
Keywords: platelet aggregation, nanoparticles, light aggregometer, quartz crystal microbalance 
with dissipation, scanning helium ion microscopy
Introduction
Humans have been increasingly exposed to nanoparticles (NPs) throughout their 
evolutionary phases, particularly in the past century due to the industrial revolution. 
Interestingly, epidemiological studies have demonstrated an association between 
exposure to ambient NPs and increased cardiovascular morbidity and mortality.1–3 
This is because NPs not only deposit in the respiratory tract but may also translocate 
to different organs in the body after penetrating the lung epithelium and entering the 
systemic circulation.4 Once in blood, the ability of NPs to interact with platelets is 
critical as it may lead to platelet aggregation and thrombus formation.5,6 In addition, 
ultrafine NPs are able to translocate from the lungs into the blood stream and directly 
impact on the clotting system.7
The growing use of nanotechnology in high-tech industries and medicine is likely 
to increase even further the exposure of humans to engineered NPs by different routes, 
leading to the translocation of nanomaterials to the vascular system.8
Potential mechanisms responsible for adverse effects of NPs on the vascular system 
are under investigation. It was previously found that mixed carbon NPs and nanotubes 
are able to induce platelet aggregation in vitro and, in addition, accelerate the rate of 
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vascular thrombosis in rat carotid artery.6 Furthermore, it has 
been found that NPs can directly induce cytotoxic morpho-
logical changes in human umbilical vein endothelial cells, 
induction of proinflammatory responses, inhibition of cell 
growth, and reduction of endothelial nitric oxide synthase.9 
Therefore, the design of new nanomaterials biocompatible 
with the vascular system and platelet function is of particular 
importance.10
Over the past five decades different methods have been 
used to study platelet aggregation. O’Brien first reported the 
use of strong hand lenses with powerful cross illumination 
to monitor platelet aggregation.11 Later, Born developed 
a simple spectrophotometer device that recorded changes 
in light transmission in response to platelet aggregation 
induced by the addition of agonists to stirred platelets.12 The 
new method, called light aggregometer, had an important 
repercussion for platelet research, and similar devices based 
on measurement of light scattering or electrical impedance13 
are routinely used worldwide. However, these instruments are 
not sensitive enough to detect the initial aggregation process 
characterized by the formation of microaggregates.14
A novel method to measure, in real time, ligand- and 
agonist-induced platelet microaggregation under low 
flow conditions using a quartz crystal microbalance with 
dissipation (QCM-D) has recently been developed.15–17
The objective of the present work was to investigate if 
QCM-D could be used for the measurement of NP-platelet 
interactions particularly under conditions where both light 
aggregometry and flow cytometry are not sensitive enough. 
Results show that QCM-D is a suitable and sensitive device 
for the detection of NP-induced platelet aggregation.
Material and methods
Reagents
All reagents were purchased from Sigma-Aldrich   Corporation 
(Dublin, Ireland), unless otherwise indicated.
Silica, polystyrene, and gold NPs
Nonporous silica microspheres (10 nm and 50 nm size) and 
plain polystyrene microspheres (60 nm size) were purchased 
from Polysciences Europe GmbH (Eppelheim, Germany).
For the preparation of gold NPs, nearly spherical NPs 
were obtained by reducing gold chloride in a controlled 
fashion. A slightly modified method of the well-known and 
frequently used methods to synthesize spherical gold NPs 
include the Turkevich method and the related Frens method 
involving the reduction of gold chloride by sodium citrate 
to produce gold NPs in hot water.18,19 The Turkevich method 
was revisited recently by Kimling et al.20 However, in the 
current study slight modifications were made to obtain well-
defined monodisperse NPs with low or no aggregation by 
controlling the temperature around 90°C. Therefore, better 
NP dispersion was able to be reproduced than in boiling 
water. An aqueous solution of 1 mmol L−1 chloroauric acid 
trihydrate (100 mL) was heated to approximately 90°C with 
stirring. A 170 mmol L−1 sodium citrate aqueous solution 
(2.82 mL) was rapidly added to the solution with mixing. 
The color of the solution changed instantly from pale yellow 
to colorless, to dark blue after approximately 70 seconds, 
and then to deep red-burgundy after 2 minutes. Stirring and 
heating of the solution was maintained for 1 hour after the 
addition of sodium citrate. The heat was then removed and 
the solution was stirred upon cooling to room temperature.21 
The NPs obtained with this procedure had a diameter of 
around 18 nm and the number of NPs was estimated to 
be ∼5.13 × 1015 L−1, assuming that all of the initial chloroauric 
acid was consumed in the process.
The size and zeta potential for all NPs tested was deter-
mined using a Zetasizer® Nano ZS (Malvern Instruments Ltd, 
Malvern, UK) at 37°C using a DTS 1060C clear disposable 
zeta cell (Malvern Instruments). Measurements were con-
ducted in triplicate at a concentration of 100 µg mL−1 with 
phosphate buffer solution for silica and polystyrene NPs and 
at 5 µg mL−1 for gold NPs. The morphology and size of the 
NPs were confirmed by using an ORION® PLUS helium ion 
microscope (Carl Zeiss AG, Oberkochen, Germany) and a 
JEM-2100 transmission electron microscope (JEOL Ltd, 
Tokyo, Japan).
Blood collection and platelet isolation
Blood was collected from healthy volunteers who had not 
taken any drugs known to affect the function of platelets for 
at least 14 days prior to the study. Platelet-rich plasma (PRP) 
was prepared from blood, as previously described,22 and 
diluted with phosphate buffer solution at final concentration 
of 250,000 platelets/µL−1. Platelet-poor plasma (PPP) 
was obtained by centrifugation of PRP at 15,000 rpm for 
10   minutes at room temperature.
Platelet aggregation measured  
by QCM-D
The principle of analysis of QCM is based on the   resonance 
frequency of a quartz crystal induced by applying an 
alternating electric field across the crystal. Deposition of 
mass on the quartz surface decreases the crystal’s oscilla-
tion frequency (negative frequency shift). For thin, rigid, 
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and uniformly distributed layers, frequency is proportional 
to the mass and can be calculated using the Sauerbrey 
equation.23 Changes in frequency as a result of platelet 
deposition on quartz crystals using QCM have been reported 
previously.24–26 However, when a soft or thick layer is bound 
to the crystal, there is also a high dissipation shift and in 
this case the mass can be underestimated by measuring 
only frequency. In fact, the combined information from 
changes in frequency and dissipation is superior to frequency 
  measurements alone.27,28 Using a QCM-D, both parameters 
can be   monitored simultaneously in real time. Therefore, 
the formation of thin films of biological materials such as 
proteins or cells can be characterized by measuring both 
frequency and dissipation.29,30
The Q-Sense® E4 QCM-D system (Q-Sense AB, Vastra 
Frolunda, Sweden) has four temperature and flow-controlled 
modules set up in parallel configuration. Samples are   perfused 
using a peristaltic microflow system (ISM 935; Ismatec SA, 
Glattbrugg, Switzerland).
For the study of platelet aggregation, polystyrene-coated 
quartz crystals with a fundamental frequency of 4.95 MHz 
were used as sensors (Q-Sense) following coating with 
fibrinogen. For fibrinogen coating, sensors were placed 
in fibrinogen dissolved in phosphate buffer solution 
(100 µg mL−1) for 1 hour at room temperature. After-
wards, sensors were mounted in the flow chamber and PRP 
  suspensions (250,000 platelets/µL−1) were perfused through 
the device at 37°C at a flow rate of 100 µL minute−1 in the 
presence of vehicle or silica NPs (100 µg mL−1 and 200 µg 
mL−1), polystyrene NPs (100 µg mL−1 and 200 µg mL−1), and 
gold NPs (5 µg mL−1). Gold NPs were shaken and silica and 
  polystyrene NPs sonicated for 10 minutes prior to aggregation 
assay. Platelet aggregation was monitored for 30 minutes in 
real time by acquisition Q-Sense software (QSoft401) and 
measured as frequency and dissipation. To study whether or 
not NPs by themselves could influence in changes in fre-
quency and dissipation, PPP was used as control. PPP was 
perfused at 100 µL minute−1 in the presence and absence of 
NPs and changes in frequency and dissipation were moni-
tored for 30 minutes.
Phase contrast microscopy
The formation of platelet aggregates on the crystal surface 
was studied using an Axiovert 200M optical microscope 
(Carl Zeiss). PRP suspensions were perfused in the presence 
of vehicle or silica NPs on fibrinogen-coated polystyrene-
coated quartz crystals for 30 minutes through the device. 
Crystals were then taken for phase contrast microscopy using a 
20× objective. Photomicrographs were captured using a digital 
camera and AxioVision software (v 4.7; Carl Zeiss).
Helium ion microscopy
For helium ion microscope imaging, PRP suspensions were 
perfused through the device in the presence of vehicle or 
silica NPs on fibrinogen-coated polystyrene-coated quartz 
crystals for 30 minutes. Afterwards, samples were fixed using 
3% glutaraldehyde for 30 minutes at 37°C. Samples were 
then dehydrated through ascending grades of ethanol (60% 
for 20 minutes, 80% for 20 minutes, 90% for 20 minutes, and 
finally 100% for 30 minutes repeated once). Samples were 
then coated with a thin gold film to reduce charging effect. 
A Carl Zeiss Orion Plus helium ion microscope was used 
to image the platelets due to its subnanometer resolution, 
efficient charge control, small beam damage, and high 
depth of field.31 The helium ion microscope was operating 
at an acceleration voltage of 32 kV and a beam current of 
approximately 3.2 pA.
Transmission electron microscopy
Gold NPs were placed on carbon-coated copper grids 
(Quantifoil Micro Tools GmbH, Jena, Germany) and left to air 
dry. The samples were then viewed using a JEOL JEM-2100 
transmission electron microscope   operating at 200 kV . All 
the micrographs were recorded on a 1.35 K × 1.04 K × 12-bit 
ES500W Erlangshen CCD   camera (Gatan, Inc, Pleasanton, 
CA). Transmission electron microscope images were 
analyzed using Image J software (National Institutes of 
Health, Bethesda, MD).
Platelet aggregation monitored  
by light aggregometry
The ability of NPs to induce platelet aggregation was   measured 
using a four-channel Whole Blood   Lumi-aggregometer 
(Chrono-Log Corporation, Havertown, PA) linked to 
  Aggrolink data reduction system (810DR; Chrono-log).6 NPs 
were sonicated for 10 minutes prior to aggregation assay. 
Platelet samples were incubated in the presence of vehicle 
or silica and polystyrene NPs at concentrations of 25, 50, 
100, 150, and 200 µg mL−1 and their effects were recorded 
for 30 minutes. Additional experiments were   performed with 
gold NPs at concentration of 5 µg mL−1. Collagen (5 µg mL−1)-
induced platelet aggregation was used as   positive control.
Flow cytometry
In order to analyze receptor expression on the surface of 
individual platelets and to minimize platelet activation caused 
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by sample preparation procedures, no stirring or vortexing 
steps were used. The abundance of P-selectin on the surface 
of platelets in the presence of silica NPs (100 µg mL−1 and 
200 µg mL−1), polystyrene NPs (200 µg mL−1), and gold 
NPs (5 µg mL−1) was measured by flow cytometry. Collagen 
(5 µg mL−1)-induced aggregation was used as positive control 
whereas resting platelets were used as negative control. 
When collagen-induced aggregation reached 50% maximal 
light transmission, samples were collected and incubated in 
the dark for 5 minutes at room temperature in the presence 
of saturating concentrations (10 µg mL−1) of P-selectin 
(CD62P-APC; BD Biosciences, Oxford, UK). Following 
incubation, samples were diluted in FACSFlow™ and 
analyzed within 5 minutes using a FACSArray™ bioanalyzer 
(BD Biosciences). Flow cytometry was performed on 
single stained platelet samples as previously described.6 
The instrument was set up to measure the size (forward 
scatter), granularity (side scatter), and cell fluorescence. 
A two-dimensional analysis gate of forward and side scatter 
was drawn in order to include single platelets and exclude 
platelet aggregates and microparticles. Antibody binding was 
measured by analyzing individual platelets for fluorescence. 
The mean fluorescence intensity was determined after 
correction for cell autofluorescence. For each sample, 
the fluorescence was analyzed using a logarithmic scale. 
Fluorescence histograms were obtained for 10,000 individual 
events. Data were analyzed using FACSArray software 
(v 1.0.3; BD Biosciences).
Statistics
For QCM-D, results are expressed as percentage of 
frequency and dissipation from the third overtone, where 
the maximal changes in frequency (negative shift) and 
dissipation (positive shift) at 30 minutes of perfusion for 
the control (250,000 platelets/µL−1) are considered as 100%. 
For light aggregometry, results are expressed as percentage 
of maximal aggregation (PPP transmission set at 100%). 
For flow cytometry, results are expressed as percentage of 
number of P-selectin copies (where the values for collagen 
are considered as 100%).
Data from at least three independent experiments were 
analyzed using GraphPad Prism (v 5.0; GraphPad Software, 
Inc, La Jolla, CA). All means are reported with standard 
deviation. Paired Student’s t-tests, one-way analyses of 
variance, and Tukey–Kramer post hoc multiple comparison 
test were performed, where appropriate. Statistical 
significance was considered when P , 0.05.
Results
NP characterization
The median size and zeta potential measured by Malvern 
ZetaSizer for all NPs tested are listed in Table 1. Due to the 
discrepancies in size between zetasizer and manufacturer’s 
specifications (silica and polystyrene), NPs were also 
examined by helium ion microscope. The size of gold NPs 
was measured using transmission electron microscope. The 
micrographs showed spherical NPs (Figure 1). The measured 
sizes (n = 9) of 50-nm silica NPs and 60-nm polystyrene NPs 
were in compliance with the manufacturer’s specifications 
(53.67 ± 13.14 and 57.67 ± 9.77 nm, respectively). The 
10-nm silica NPs showed a size of 16.56 ± 4.77 nm and 
some tendency to agglomeration. The gold NPs showed a 
size of 16.5 ± 2 nm.
Effects of NPs on platelet aggregation  
as measured by QCM-D and microscopy
The perfusion of physiological concentrations of platelets 
(250,000 platelets/µL−1) on polystyrene-coated quartz 
crystals induced a decrease in frequency and an increase 
in dissipation indicating the deposition of platelet aggre-
gates on the sensor surface (Figure 2A). Incubation of 
platelets with 50-nm silica NPs at concentrations up to 
200 µg mL−1 significantly induced changes in frequency 
and in dissipation (Figure 3A). In addition, as compared 
to controls 10-nm silica NPs (100 µg mL−1) also increased 
dissipation (Figure 3B). These effects were confirmed by 
phase contrast microscopy (Figure 2B) and helium ion 
microscopy which showed the presence of bigger platelet 
aggregates on the surface of the crystals after the perfusion 
of PRP in the presence of NPs (Figure 4). Furthermore, 
as shown in Figure 5, incubation of platelets with 60-nm 
polystyrene NPs at concentrations up to 200 µg mL−1 also 
induced significant changes in frequency and in dissipation. 
In addition, incubation of platelets with 18-nm gold NPs at 
Table 1 Characterization of silica, polystyrene, and gold nano-
particles
Type Mean size  
(nm)
Polydispersity  
index
Zeta potential   
(mV)
10 nm SiO2 NPs      39 ± 0.2758 0.326 ± 0.004 −24.8 ± 2.38
50 nm SiO2 NPs 112.6 ± 1.951 0.171 ± 0.008 −25.5 ± 0.915
60 nm PS NPs      71 ± 1.254 0.012 ± 0.009 −45.5 ± 0.904
18 nm Au NPs      22 ± 1.5   0.22 ± 0.05     −31 ± 1
Note: Samples represent the mean and standard deviation from three measurements. 
Abbreviations: Au NPs, gold nanoparticles; PS NPs, polystyrene nanoparticles; 
SiO2 NPs, silica nanoparticles.
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5 µg mL−1 also induced a significant increase in dissipation 
as shown in Figure 6.
In order to know whether or not NPs were able to induce 
changes in frequency and in dissipation on their own, PPP in 
the absence and presence of silica, polystyrene, and gold NPs 
were perfused through the crystals. No significant changes 
were found in frequency and dissipation when PPP was 
incubated with NPs (Figure 7).
Effects of NPs on platelet aggregation  
as measured by light aggregometry
The 10-nm silica NPs induced platelet aggregation at 
200 µg mL−1, but not at lower concentrations (25, 50, and 
100 µg mL−1) (Figure 8A and B). Incubation of PRP with 
silica NPs (50 nm), polystyrene NPs (60 nm) at concentra-
tions up to 200 µg mL−1 and gold NPs (18 nm) at 5 µg mL−1 
did not induce platelet aggregation (Figure 8C–E). As 
expected, incubation of platelets with collagen (5 µg mL−1) 
resulted in platelet aggregation (Figure 8).
Effects of NPs on P-selectin abundance
Flow cytometry was used to study the effects of silica, 
polystyrene, and gold NPs on the abundance of P-selectin. 
Incubation of resting platelets with 10-nm silica NPs at 
200 µg mL−1, but not at lower concentrations, induced a 
significant increase in the number of P-selectin copies on 
platelet surface. However, incubation of PRP with silica NPs 
(50 nm), polystyrene NPs (60 nm) up to 200 µg mL−1, and 
gold NPs (18 nm) at 5 µg mL−1 did not change the expression 
of P-selectin on the platelet surface. As expected, incubation 
of platelets with collagen (5 µg mL−1) resulted in significant 
upregulation of P-selectin in platelets (Figure 9).
Discussion
There is increasing evidence that exposure of humans to NPs 
could lead to pharmacological and toxicological effects in 
the cardiovascular system.1,5,7 It has been found that inhaled 
NPs may cause systemic inflammation and oxidative stress, 
which mediate endothelial dysfunction and atherosclerosis.4 
In addition, NPs may interact in the bloodstream with 
  platelets leading to platelet activation, aggregation, and 
vascular thrombosis.6,32 Therefore, it is necessary to ensure 
that engineered NPs are blood compatible before their use 
in humans or in human environment.
To date, most data on biology, physiology, and pharma-
cology of platelet aggregation has been obtained by studying 
100 nm 100 nm
100 nm
10 nm SiO2 NPs 50 nm SiO2 NPs
60 nm PS NPs 
A B
C
18 nm Au NPs
D
Figure 1 Helium scanning micrographs of (A) 10-nm silica nanoparticles, (B) 50-nm silica nanoparticles, and (C) 60-nm polystyrene nanoparticles and transmission electron 
micrographs of (D) 18-nm gold nanoparticles. 
Abbreviations: Au NPs, gold nanoparticles; PS NPs, polystyrene nanoparticles; SiO2 NPs, silica nanoparticles.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
247
Nanoparticle-induced platelet aggregation using QCM-DInternational Journal of Nanomedicine 2012:7
this phenomenon using light aggregometer that stands as the 
“traditional gold standard” for the measurement of platelet 
aggregation.33 However, the use of light aggregometer to 
detect and measure NP-induced platelet aggregation is 
limited. Indeed, the instrument is not sensitive enough to 
detect microaggregates; it operates only in no-flow mode and 
therefore does not mimic flow-mediated aggregation events 
encountered in the microvasculature.14,34 A new method for 
the characterization of platelet microaggregation at nanoscale 
under flow conditions has recently been developed using 
QCM-D technology.15–17 Using this device, the aim was to 
investigate the proaggregatory effects of three different NPs 
and compare the data obtained from QCM-D experiments to 
results generated by standard methods that measure platelet 
activation with a higher (flow cytometry) and lower (light 
aggregometer) sensitivity.
Silica and polystyrene NPs were selected for these 
  experiments as they are largely used in different technological 
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Figure 2 Effects of silica nanoparticles on platelet aggregation using quartz crystal microbalance with dissipation. Perfusion of fibrinogen-coated polystyrene-coated quartz 
crystals with platelet-rich plasma in the presence of silica nanoparticles leads to platelet aggregation. (A) Representative traces from the third overtone recorded by the 
device showing the effects of platelet-rich plasma in the presence or absence of silica nanoparticles on frequency (blue line, left axis) and dissipation (red line, right axis).   
(B)  Representative  micrographs  of  the  surface  of  fibrinogen-coated  polystyrene-coated  quartz  crystals  as  viewed  by  phase  contrast  microscopy  showing  increased 
accumulation of platelet aggregates following perfusion of platelet-rich plasma in the presence of silica nanoparticles. 
Abbreviations: min, minutes; PRP, plasma-rich protein; sec, seconds.
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Figure 3 Quantitative analysis of the effects of silica nanoparticles on frequency and energy dissipation (from the third overtone), where the maximal changes in frequency 
(negative shift) and dissipation (positive shift) for the control are considered as 100%. (A) Incubation of platelets with 50-nm silica nanoparticles at concentrations up to 
200 µg mL−1 significantly induced changes in frequency and dissipation. (B) Incubation of platelets with 10-nm silica nanoparticles (100 µg mL−1) significantly induced changes 
in dissipation. 
Notes: Data are expressed as mean ± standard deviation. *P , 0.05; **P , 0.01; ***P , 0.001.
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Figure 4 Representative micrographs of the surface of fibrinogen-coated polystyrene-coated quartz crystals as viewed by helium ion microscopy after the perfusion of 
platelet-rich plasma (A) and platelet-rich plasma in the presence of 10-nm silica nanoparticles (B) and 50-nm silica nanoparticles (C). Increased accumulation of platelet 
aggregates and bigger aggregates induced by the perfusion of platelet-rich plasma in the presence of silica nanoparticles is shown.
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Figure 5 Effects of polystyrene nanoparticles on platelet aggregation using quartz crystal microbalance with dissipation. Perfusion of fibrinogen-coated polystyrene-coated 
quartz crystals with platelet-rich plasma in the presence of polystyrene nanoparticles leads to platelet aggregation. (A) Representative traces from the third overtone 
recorded by the device showing the effects of platelet-rich plasma in the presence or absence of polystyrene nanoparticles on frequency (blue line, left axis) and dissipation 
(red line, right axis). (B) Quantitative analysis of the effects of polystyrene nanoparticles on frequency and dissipation. Incubation of platelets with 60-nm polystyrene 
nanoparticles at concentrations up to 200 µg mL−1 significantly induced changes in frequency and dissipation. 
Notes: Data are expressed as mean ± standard deviation. *P , 0.05. 
Abbreviations: min, minutes; PRP, plasma-rich protein; sec, seconds.
and pharmaceutical applications.35,36 Silica and polystyrene 
NPs of different sizes and concentrations were used to study 
their interactions with human platelets. In addition, further 
studies were performed with gold NPs as they are increas-
ingly used in biotechnology.37 In order to corroborate NP 
characteristics, their size, morphology, and zeta potential 
were evaluated prior to pharmacological studies. When 
evaluating toxicological effects of NPs, it would be   desirable 
to disperse NPs in aqueous solutions as agglomeration could 
influence toxicological studies by affecting cellular uptake 
or biodistribution of NPs.38 A good dispersion of all NPs 
with sizes consistent with singlet NP was found. Silica and 
polystyrene NPs did not diverge from the manufacturer’s 
specifications.
It was previously found that engineered carbon multi-
walled and single-walled nanotubes and mixed carbon NPs 
were able to induce platelet activation and aggregation in 
washed platelets in vitro.6 However, PRP was used in this 
study as it has been suggested that proteins coating the surface 
of NPs lead to the formation of a “protein corona” that can 
change the biological properties of the NPs39 and, therefore, 
might modify the effects of NPs on platelets. Consequently, 
it would be desirable to test the blood compatibility of dif-
ferent NPs in the presence of plasma proteins. In a study of 
the interactions between polystyrene NPs (different sizes 
and charges) and human plasma proteins, Lundqvist et al39 
showed that, even though many of the major highly abundant 
proteins in the corona are independent of size and surface 
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Figure 6 Effects of gold nanoparticles on platelet aggregation using quartz crystal microbalance with dissipation. Perfusion of fibrinogen-coated polystyrene-coated quartz 
crystals with platelet-rich plasma in the presence of gold nanoparticles leads to platelet aggregation. (A) Representative traces from the third overtone recorded by the 
device showing the effects of platelet-rich plasma in the presence or absence of gold nanoparticles on frequency (blue line, left axis) and dissipation (red line, right axis).   
(B) Quantitative analysis of the effects of gold nanoparticles on frequency and dissipation. 
Notes: Data are expressed as mean ± standard deviation. *P , 0.05. 
Abbreviations: min, minutes; PRP, plasma-rich protein; sec, seconds.
charge, a whole range of different proteins coat the surface 
of polystyrene NPs.
The ability of single-walled nanotubes to induce platelet 
aggregation in PRP has been previously reported in a study 
by Bihari et al.40 In the present experiments, only the small-
est NPs tested (10 nm silica) at a concentration of 200 µg 
mL−1 were able to induce platelet aggregation in PRP as 
measured by aggregometry. This could be explained by the 
fact that the smaller the particle, the more surface area they 
have per unit mass; therefore any intrinsic toxicity of the 
particle   surface would be enhanced.41 In fact, the rest of the 
NPs tested were not able to induce platelet aggregation as 
measured by aggregometry. However, in control experiments, 
incubation of platelets with collagen resulted in platelet 
aggregation, showing that platelets – that did not aggregate 
in response to silica, polystyrene, or gold NPs – reacted as 
expected to the presence of a physiological stimulant. These 
results correlated well with the abundance of P-selectin on 
platelet surface as measured by flow cytometry. Platelet acti-
vation is associated with the surface abundance of receptors 
that play an important role in adhesion, aggregation, and 
platelet-leukocyte aggregation. P-selectin is mainly stored 
in platelet alpha-granules and upon platelet activation is 
translocated to the platelet surface, mediating leukocyte 
rolling and the formation of platelet–leukocyte aggregates.42 
P-selectin is, in fact, one of the most sensitive markers of 
platelet activation; therefore, any changes in the abundance 
of this receptor induced by NPs could potentially indicate 
undesirable effects on human platelets. In fact, P-selectin 
has been previously used as a marker of platelet activation 
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Figure 7 Effects of silica, polystyrene, and gold nanoparticles on platelet-poor plasma using quartz crystal microbalance with dissipation. Perfusion of fibrinogen-coated 
polystyrene-coated quartz crystals with platelet-poor plasma in the presence of silica, polystyrene, and gold nanoparticles did not induce significant changes in frequency 
and dissipation. Representative traces from the third overtone recorded by the device showing the effects of platelet-poor plasma in the presence or absence of (A) silica 
nanoparticles, (B) polystyrene nanoparticles, and (C) gold nanoparticles on frequency (blue line, left axis) and dissipation (red line, right axis). 
Abbreviation: min, minutes; PPP, platelet-poor plasma; sec, seconds.
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Figure 8 Effects of silica, polystyrene, and gold nanoparticles on platelet aggregation using light aggregometer. (A) Representative traces from aggregometry studies in platelet-rich 
plasma in the presence or absence of 10-nm silica nanoparticles. Collagen (blue line) was used as a positive control; stirring platelets in the absence of nanoparticles (black line) 
were used as negative control. Only 200 µg mL−1 (green line) induced significant platelet aggregation. Quantitative analysis of (B) 10-nm silica nanoparticles with all concentrations 
tested, (C) 50-nm silica nanoparticles with all concentrations tested, (D) 60-nm polystyrene nanoparticles with all concentrations tested, and (E) gold nanoparticles. 
Notes: Data expressed as mean ± standard deviation. ***P , 0.001 versus stirring. 
Abbreviations: Au, gold; min, minutes; PS, polystyrene; sec, seconds; SiO2, silica.
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in engineered NP research.6 Indeed, the present results are in 
agreement with Bilhari et al,40 who demonstrated P-selectin 
translocation to the platelet surface after incubation of whole 
blood with single-walled nanotubes.
When the interactions between silica, polystyrene, and 
gold NPs with human platelets were studied under flow 
conditions by QCM-D, it was found that the perfusion of 
fibrinogen-coated polystyrene-coated quartz crystals with 
PRP led, as monitored in real time by the device, to accu-
mulation of platelet mass on the sensor surface as shown by 
changes in frequency and dissipation and confirmed by phase 
contrast microscopy and helium ion microscopy. Although 
changes in frequency and dissipation reflect the deposition 
of adhering platelets and small aggregates on crystals, the 
deposition of bigger aggregates is more accurately reflected 
by changes in dissipation.15,16 Interestingly, QCM-D was not 
only able to detect platelet aggregation induced by 10-nm 
silica NPs at lower concentration in contrast to aggregometry 
and flow cytometry, but also to detect NP-induced platelet 
aggregation when PRP was incubated with 50-nm silica, 
60-nm polystyrene, and 18-nm gold NPs. As QMC-D is a 
very sensitive device and can detect nanograms of mass, it 
was studied whether or not NPs on their own or via interac-
tions with plasma proteins could be responsible for changes 
in frequency and dissipation. As shown in PPP studies, 
no NPs at concentrations used were able to significantly 
induce changes in frequency and dissipation as compared 
to NP-free PPP.
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Figure 9 Effects of silica, polystyrene, and gold nanoparticles on platelet receptors. (A) Representative flow cytometry recordings showing analysis of P-selectin on platelets 
in the presence and absence (resting) of 10-nm and 50-nm silica and polystyrene nanoparticles (up to 200 µg mL−1) and 18-nm gold nanoparticles (5 µg mL−1). Collagen 
(5 µg mL−1) was used as positive control. (B) Quantitative analysis of the effects of silica, polystyrene, and gold nanoparticles on P-selectin. 
Notes: Data expressed as mean ± standard deviation. *P , 0.05; ***P , 0.001 versus resting. 
Abbreviations: Au, gold; PS, polystyrene; SiO2, silica.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
253
Nanoparticle-induced platelet aggregation using QCM-DInternational Journal of Nanomedicine 2012:7
Conclusion
In summary, it has been demonstrated here for the first 
time that QMC-D is a useful and sensitive tool to study 
NP-induced platelet aggregation. Thus, this device should 
be considered when testing blood compatibility of new 
engineered NPs.
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